Alpheus Medical Raises $52 Million in Series B
Alpheus Medical has raised $52 million in an oversubscribed Series B funding round to support a randomized Phase 2B clinical trial to evaluate its non-invasive sonodynamic treatments for patients newly diagnosed with glioblastoma. The financing…